PTC Therapeutics, Inc. (PTCT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

48.44

-0.42

(-0.86%)

At close: 04:00PM EDT

49.00

+0.56

(+1.16%)

After hours:

06:42PM EDT

Loading interactive chart…

Zacks
Reata (RETA) Stock Jumps as FDA Approves Rare Disease Drug
Skyclarys is the first drug to be approved specifically for the treatment of Friedreich's ataxia and is also Reata Pharmaceuticals' (RETA) first commercial product
Simply Wall St.
When Can We Expect A Profit From PTC Therapeutics, Inc. (NASDAQ:PTCT)?
With the business potentially at an important milestone, we thought we'd take a closer look at PTC Therapeutics, Inc.'s...
Zacks
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -19.90% and 6.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?